Status:
NOT_YET_RECRUITING
Research on the Improvement of Intestinal and Immune Functions by Probiotics
Lead Sponsor:
Wecare Probiotics Co., Ltd.
Conditions:
Intestinal Health
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Evaluate the effectiveness and safety of Limosilactobacillus fermentum LF61 as a food supplement compared to a placebo in improving intestinal and immune functions in healthy adults.
Eligibility Criteria
Inclusion
- Willing to undergo 3 follow-up visits during the intervention period
- Be willing to provide blood, urine and stool samples 2 times during the intervention period
- Willing to self-administer one of the 7 probiotics (BI45, BBi32, LS97, LB42, LF61, LH76, LR08)/placebo once a day during the intervention period
- Good eyesight, can read and write, can wear glasses
- Have good hearing and be able to hear and understand all instructions during the intervention -
Exclusion
- Digestive diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease)
- Have a serious neurological condition (epilepsy, stroke, severe head trauma, meningitis in the last 10 years, brain surgery, brain tumor, prolonged coma - not including general anaesthesia)
- Have received/are receiving treatment for the following mental disorders: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder
- Take medication for depression or low mood
- Internal organ failure (heart, liver or kidney failure, etc.)
- Have received radiation or chemotherapy in the past
- have undergone a general anesthesia procedure/procedure within the past three years, or plan to undergo a general anesthesia procedure/procedure within the next 3 months during this trial period
- Have had hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past -
Key Trial Info
Start Date :
March 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06873425
Start Date
March 10 2025
End Date
December 30 2025
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xu fei
Zhengzhou, Henan, China, 210095